Entod Pharma News Today

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

The healthcare and pharmaceutical sectors are experiencing a positive shift with more and more women making big strides. But, it is still a challenge to reach leadership positions

Designed with state-of-the-art equipment and the latest analytical & formulation research tools

The products have been launched under the brands Eyecirque, Lashfactor and Vasuki

The products have been launched under the brands Eyecirque, Lashfactor and Vasuki

Razel and its combinations are meant for the management of dyslipidemia. The condition has abnormally elevated cholesterol or fats (lipids) in the blood which may increase the chance of clogged arteries and heart attacks.

Entod Pharmaceuticals has over 270 therapeutic solutions covering all major eye health issues along with those encompassing ENT and dermatology

Vasuki facial gel serum is one of the world’s first clinically proven topical neurotoxins

Launches ENTOD Beauty London products in India

Launches ENTOD Beauty London products in India